With direct letters, regulatory comments and other activities, Vizient strives to form constructive relationships with lawmakers, regulatory agencies and administration officials, to provide a unified voice on issues that have a direct impact on our members.

Advocacy 2023

September 20 – Vizient endorses the Safety from Violence for Healthcare Employees (SAVE) Act

September 11 – Vizient comments to the Food and Drug Administration (FDA) on Implementation Challenges Associated with the Drug Supply Chain Security Act (DSCSA)

September 11 – Vizient comments to the Centers for Medicare & Medicaid Services (CMS) on the calendar year (CY) 2024 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) proposed rule

September 11 – Vizient comments to the Centers for Medicare & Medicaid Services (CMS) on the calendar year (CY) 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule

September 1 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022

August 17 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Request for Information (RFI) regarding the design of a future episode-based payment model

July 21 – Vizient endorses the Biosimilar Red Tape Elimination Act

July 3 – Vizient endorses the Drug Origin Transparency Act

June 27 – Vizient comments to the Environmental Protection Agency (EPA) on the proposed rule on “National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review”

June 27 – Vizient comments to the Environmental Protection Agency (EPA) on the proposed interim decisions for ethylene oxide (EtO) and the draft risk assessment addendum

June 20 – Vizient comments to the Food and Drug Administration (FDA) on the Global Unique Device Identification (GUDID)_ACCESS Database

June 20 – Vizient comments to the Office of the National Coordinator (ONC) on the proposed rule regarding the Health Data, Technology, and Interoperability

June 14 – Vizient endorses the Preserving Patient Access to Home Infusion Act

June 12 – Policy Solutions to Address Prescription Drug Shortages

June 7 – Vizient endorses the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023

June 9 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the FY 2024 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System proposed rule

May 30 – Vizient endorses the Biologics Competition Act of 2023

May 23 – Vizient endorsed coalition letter in opposition to Section 302 of H.R. 3561 and additional site-neutral payment policies

May 17 – Vizient endorses the Rural Hospital Closure Relief Act of 2023

May 17 – Vizient endorses the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2023

May 8 – Vizient endorses the Resident Physician Shortage Reduction Act

May 1 – Vizient comments to CMS on the Medicare Disproportionate Share Hospital Payments: Counting Certain Days Associated with Section 1115 Demonstrations in the Medicaid Fraction proposed rule

April 21 - Vizient comments to Centers for Medicare & Medicaid Services (CMS) on the Medicaid Program Disproportionate Share Hospital Third-Party Payer Rule

April 21 - Vizient endorses the Supporting Safety Net Hospitals Act

April 19 - Vizient endorses the Safety from Violence for Healthcare Employees (SAVE) Act.

April 17 - Vizient comments to the Office of the National Coordinator (ONC) on the United States Core Data for Interoperability (USCDI) Draft Version 4

April 14 - Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on Medicare Drug Price Negotiation Program Guidance

April 12 - Vizient comments to the Office of Management and Budget (OMB) on Initial Proposals for Updating Race and Ethnicity Statistical Standards

April 11 - Vizient endorses the Preserving Rules Ordered for the Entities Covered Through (PROTECT) 340B Act

April 11 - Vizient endorses the Save Rural Hospitals Act

March 31 – Vizient endorses the Resident Physician Shortage Reduction Act of 2023

March 31 – Vizient comments on the Drug Enforcement Administration (DEA) Proposed Rule on telemedicine prescribing of controlled substances

March 31 – Vizient comments on the Drug Enforcement Administration (DEA) Proposed Rule to expand access to buprenorphine via telemedicine encounters

March 31 – Vizient comments on the Centers for Medicare and Medicaid Services (CMS) Medicare Part B Inflation Rebate Program Guidance1 and Medicare Part D Inflation Rebate Program Initial Guidance

March 29 – Vizient responds to the Senate Health, Education, Labor & Pensions (HELP) Committee’s Request for Information (RFI) on upcoming PAHPA reauthorization

March 21 - Vizient endorsed coalition letter calling for $738 million in FY 2024 funding for Children’s Hospital Graduate Medical Education (CHGME)

March 20 - Vizient comments to the to the Department of Labor (DoL) Employment and Training Administration (ETA) on the request for information (RFI) on sector strategies to meet critical workforce needs across industries, including healthcare.

March 20 - Vizient comments to the Senate Health, Education, Labor & Pensions (HELP) Committee on the request for information (RFI) regarding healthcare workforce challenges

March 13 - Vizient shares feedback with House members on the reauthorization of the Pandemics and All-Hazards Preparedness Act (PAHPA)

March 13 - Vizient comments to CMS on prior authorization proposed rule

March 6 - Vizient urges Congress to address the Medicaid disproportionate share hospital (DSH) cuts scheduled to begin in fiscal year (FY) 2024

February 13 - Vizient comments to CMS on the Contract Year 2024 Medicare Advantage and Part D Proposed Rule

February 2 - Vizient submits comments to FDA regarding Drug Supply Chain Security Act (DSCSA) Implementation and Readiness Efforts for 2023

January 31 - Vizient submits comments to HHS regard Confidentiality of Substance Use Disorder Patient Records

January 30 - Vizient submits comments to HRSA regarding proposed revisions to the current 340B administrative dispute resolution final rule

January 26 - Vizient comments to the Agency for Healthcare Research and Quality (AHRQ) on the request for information (RFI) on Creating a National Healthcare System Action Alliance To Advance Patient Safety

January 12 - Vizient comments to the National Quality Forum (NQF) on the Measure Application Partnership’s (MAP) draft recommendations for CMS

January 9 - Vizient letter to CMS on 340B Remedy for Repayment of Unlawful Cuts to Part B 340B-Purchased Drugs

Connect with Vizient to help you solve health care’s biggest challenges